NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.180
+0.140 (4.61%)
At close: Oct 17, 2025, 4:00 PM EDT
3.240
+0.060 (1.89%)
After-hours: Oct 17, 2025, 7:59 PM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $75.59 million as of October 17, 2025. Its market cap has increased by 345.01% in one year.
Market Cap
75.59M
Enterprise Value
82.53M
1-Year Change
345.01%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since December 4, 2017, NRx Pharmaceuticals's market cap has decreased from $82.80M to $75.59M, a decrease of -8.71%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 75.59M | 184.88% |
| Dec 31, 2024 | 26.53M | -30.71% |
| Dec 29, 2023 | 38.30M | -48.99% |
| Dec 30, 2022 | 75.08M | -73.29% |
| Dec 31, 2021 | 281.11M | 328.57% |
| Dec 31, 2020 | 65.59M | 1.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |